News
Grifols acquires 40% of the capital of biotechnology firm VCN Bioscience
Grifols the world’s third largest plasma product manufacturer and a pioneer in the research and development of therapeutic alternatives designed to contribute to both scientific and social development, has acquired 40% of the equity of Catalan biotechnology firm VCN Biosciences, dedicated to the research and development of new therapeutic approaches for tumors for which there […]
Barbara Marte, Nature editor: ”Now we are publishing more documents than ever”
Nature, first published on 1869, is the leading weekly, international scientific journal. Most scientific journals are now highly specialized, and Nature is among the few journals that still publish original research articles across a wide range of scientific fields. Nature is a private owned publication. The Nature Published Group (NPG) includes Nature, Nature Research Journals, […]
The activation of VRK1, new step in the response to DNA damage
Relationship between cancer and VRK1, a chromatin kinase implicated in DNA damage responses, related to neurodegenerative diseases. The group of Pedro A. Lazo, researcher at the Institute of Molecular and Cellular Biology of Cancer, from CSIC and the University of Salamanca, is investigating the role of VRK1 kinase in response to cell damage and how […]
Manel Esteller opens the First International Conference on Biology of Catalonia
The First International Conference of Biology of Catalonia joins more than eight hundred scientists from around the world The First International Conference on Biology of Catalonia, entitled “Global advanced questions on Biology,” will be opened with the conference “Epigenètica: de la biologia a la malaltia” by Manel Esteller, researcher at the Bellvitge Biomedical Research Institute […]
Alliance to develop new personalized treatments against lung cancer
The Bellvitge Biomedical Research Institute (IDIBELL) has participated in the “Cancer of lungs: the molecular knowledge to treatment” international meeting co-organized with the Centre for Applied Medical Research (CIMA), from the University of Navarra. This event, framed within the Curelung project funded by the European Commission, brought international experts who presented the latest scientific and […]
Jaume Reventós: “We need to learn how dogs find cancer by the smell”
Jaume Reventós, PhD, from VHIR, gave a lecture at the hall of the Hospital Duran i Reynals (ICO) on last 29th June. He questioned the current diagnostic tests for prostate cancer and he talked about the kit he is developing to prevent up to 34% of current biopsies. He also spoke of the study about […]
Six students will live the summer in IDIBELL
Six students will have the opportunity to complete their formation in one of the IDIBELL research groups. The training will last three months, from July to September. The students have finished the last course of a biomedical bachelor’s program. The Scientific Direction of IDIBELL has evaluated the applications received and has announced the awarded of […]
F. Xavier Bosch, Lilly Foundation for Biomedical Research award 2012
Delivery of the Lilly Foundation for Biomedical Research award 2012 F. Xavier Bosch, researcher at IDIBELL/ICO and world leader in human papilloma virus and cervical cancer, has received the Lilly Foundation for Biomedical Research award 2012 in the preclinical research category. Dr. Felipe Casanueva, scientific director of CIBERobn, who has contributed to international understanding of […]
Manel Esteller receives a Merck Serono Research grant
Dr. Manel Esteller, from the Bellvitge Biomedical Research Institute (IDIBELL), has received a Merck Serono Research grant in the research area in molecular basis of rare diseases and their clinical implications for the project “Epigenetic characterization of Sotos Syndrome. Evaluation of the pharmacological treatments use aimed at enhancing the expression of microRNAs”. After 20 years, […]